Fennec Pharmaceuticals (FENC) Profit After Tax: 2011-2025
Historic Profit After Tax for Fennec Pharmaceuticals (FENC) over the last 15 years, with Sep 2025 value amounting to -$638,000.
- Fennec Pharmaceuticals' Profit After Tax rose 88.88% to -$638,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 512.53%. This contributed to the annual value of -$436,000 for FY2024, which is 97.28% up from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Profit After Tax stood at -$638,000, which was up 79.76% from -$3.2 million recorded in Q2 2025.
- Over the past 5 years, Fennec Pharmaceuticals' Profit After Tax peaked at $12.8 million during Q1 2024, and registered a low of -$10.3 million during Q4 2022.
- Its 3-year average for Profit After Tax is -$1.9 million, with a median of -$2.7 million in 2023.
- Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' Profit After Tax showed a top increase of 312.11% in 2024 and a maximum decrease of 207.18% in 2024.
- Over the past 5 years, Fennec Pharmaceuticals' Profit After Tax (Quarterly) stood at -$4.2 million in 2021, then plummeted by 89.66% to -$10.3 million in 2022, then skyrocketed by 74.04% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then surged by 88.88% to -$638,000 in 2025.
- Its Profit After Tax stands at -$638,000 for Q3 2025, versus -$3.2 million for Q2 2025 and -$1.2 million for Q1 2025.